Experimental Selection of Paromomycin Resistance in <i>Leishmania donovani</i> Amastigotes Induces Variable Genomic Polymorphisms

The relatively high post-treatment relapse rates of paromomycin (PMM) in visceral leishmaniasis treatment and the swift emergence of experimental drug resistance challenge its broad application and urge for rational use and monitoring of resistance. However, no causal molecular mechanisms to <i&g...

Full description

Bibliographic Details
Main Authors: Sarah Hendrickx, João Luís Reis-Cunha, Sarah Forrester, Daniel C. Jeffares, Guy Caljon
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/9/8/1546
_version_ 1797522886179684352
author Sarah Hendrickx
João Luís Reis-Cunha
Sarah Forrester
Daniel C. Jeffares
Guy Caljon
author_facet Sarah Hendrickx
João Luís Reis-Cunha
Sarah Forrester
Daniel C. Jeffares
Guy Caljon
author_sort Sarah Hendrickx
collection DOAJ
description The relatively high post-treatment relapse rates of paromomycin (PMM) in visceral leishmaniasis treatment and the swift emergence of experimental drug resistance challenge its broad application and urge for rational use and monitoring of resistance. However, no causal molecular mechanisms to <i>Leishmania</i> PMM resistance have been identified so far. To gain insights into potential resistance mechanisms, twelve experimentally selected <i>Leishmania donovani</i> clonal lines and the non-cloned preselection population, with variable degrees of PMM resistance, were subjected to whole genome sequencing. To identify genomic variations potentially associated with resistance, SNPs, Indels, chromosomal somy and gene copy number variations were compared between the different parasite lines. A total of 11 short nucleotide variations and the copy number alterations in 39 genes were correlated to PMM resistance. Some of the identified genes are involved in transcription, translation and protein turn-over (<i>transcription elongation factor-like protein</i>, <i>RNA-binding protein, ribosomal protein L1a, 60S ribosomal protein L6, eukaryotic translation initiation factor 4E-1, proteasome regulatory non-ATP-ase subunit 3</i>), virulence (<i>major surface protease gp63, protein-tyrosine phosphatase 1-like protein</i>), mitochondrial function (<i>ADP/ATP mitochondrial carrier-like protein</i>), signaling (<i>phosphatidylinositol 3-related kinase</i>, <i>protein kinase putative</i> and <i>protein-tyrosine phosphatase 1-like protein</i>) and vesicular trafficking (<i>ras-related protein RAB1</i>). These results indicate that, in <i>Leishmania</i>, the aminoglycoside PMM affects protein translational processes and underlines the complex and probably multifactorial origin of resistance.
first_indexed 2024-03-10T08:35:43Z
format Article
id doaj.art-fcd24c9f5d754ac6be7f30ebcfe432cb
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-03-10T08:35:43Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-fcd24c9f5d754ac6be7f30ebcfe432cb2023-11-22T08:45:19ZengMDPI AGMicroorganisms2076-26072021-07-0198154610.3390/microorganisms9081546Experimental Selection of Paromomycin Resistance in <i>Leishmania donovani</i> Amastigotes Induces Variable Genomic PolymorphismsSarah Hendrickx0João Luís Reis-Cunha1Sarah Forrester2Daniel C. Jeffares3Guy Caljon4Laboratory of Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, 2610 Antwerp, BelgiumDepartment of Biology and York Biomedical Research Institute, University of York, York YO31 5DD, UKDepartment of Biology and York Biomedical Research Institute, University of York, York YO31 5DD, UKDepartment of Biology and York Biomedical Research Institute, University of York, York YO31 5DD, UKLaboratory of Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, 2610 Antwerp, BelgiumThe relatively high post-treatment relapse rates of paromomycin (PMM) in visceral leishmaniasis treatment and the swift emergence of experimental drug resistance challenge its broad application and urge for rational use and monitoring of resistance. However, no causal molecular mechanisms to <i>Leishmania</i> PMM resistance have been identified so far. To gain insights into potential resistance mechanisms, twelve experimentally selected <i>Leishmania donovani</i> clonal lines and the non-cloned preselection population, with variable degrees of PMM resistance, were subjected to whole genome sequencing. To identify genomic variations potentially associated with resistance, SNPs, Indels, chromosomal somy and gene copy number variations were compared between the different parasite lines. A total of 11 short nucleotide variations and the copy number alterations in 39 genes were correlated to PMM resistance. Some of the identified genes are involved in transcription, translation and protein turn-over (<i>transcription elongation factor-like protein</i>, <i>RNA-binding protein, ribosomal protein L1a, 60S ribosomal protein L6, eukaryotic translation initiation factor 4E-1, proteasome regulatory non-ATP-ase subunit 3</i>), virulence (<i>major surface protease gp63, protein-tyrosine phosphatase 1-like protein</i>), mitochondrial function (<i>ADP/ATP mitochondrial carrier-like protein</i>), signaling (<i>phosphatidylinositol 3-related kinase</i>, <i>protein kinase putative</i> and <i>protein-tyrosine phosphatase 1-like protein</i>) and vesicular trafficking (<i>ras-related protein RAB1</i>). These results indicate that, in <i>Leishmania</i>, the aminoglycoside PMM affects protein translational processes and underlines the complex and probably multifactorial origin of resistance.https://www.mdpi.com/2076-2607/9/8/1546paromomycinresistancesequencingSNPCNV
spellingShingle Sarah Hendrickx
João Luís Reis-Cunha
Sarah Forrester
Daniel C. Jeffares
Guy Caljon
Experimental Selection of Paromomycin Resistance in <i>Leishmania donovani</i> Amastigotes Induces Variable Genomic Polymorphisms
Microorganisms
paromomycin
resistance
sequencing
SNP
CNV
title Experimental Selection of Paromomycin Resistance in <i>Leishmania donovani</i> Amastigotes Induces Variable Genomic Polymorphisms
title_full Experimental Selection of Paromomycin Resistance in <i>Leishmania donovani</i> Amastigotes Induces Variable Genomic Polymorphisms
title_fullStr Experimental Selection of Paromomycin Resistance in <i>Leishmania donovani</i> Amastigotes Induces Variable Genomic Polymorphisms
title_full_unstemmed Experimental Selection of Paromomycin Resistance in <i>Leishmania donovani</i> Amastigotes Induces Variable Genomic Polymorphisms
title_short Experimental Selection of Paromomycin Resistance in <i>Leishmania donovani</i> Amastigotes Induces Variable Genomic Polymorphisms
title_sort experimental selection of paromomycin resistance in i leishmania donovani i amastigotes induces variable genomic polymorphisms
topic paromomycin
resistance
sequencing
SNP
CNV
url https://www.mdpi.com/2076-2607/9/8/1546
work_keys_str_mv AT sarahhendrickx experimentalselectionofparomomycinresistanceinileishmaniadonovaniiamastigotesinducesvariablegenomicpolymorphisms
AT joaoluisreiscunha experimentalselectionofparomomycinresistanceinileishmaniadonovaniiamastigotesinducesvariablegenomicpolymorphisms
AT sarahforrester experimentalselectionofparomomycinresistanceinileishmaniadonovaniiamastigotesinducesvariablegenomicpolymorphisms
AT danielcjeffares experimentalselectionofparomomycinresistanceinileishmaniadonovaniiamastigotesinducesvariablegenomicpolymorphisms
AT guycaljon experimentalselectionofparomomycinresistanceinileishmaniadonovaniiamastigotesinducesvariablegenomicpolymorphisms